Session 82
Healthy Life Expectancies II

Note: Due to the pandemic the original sessions have been cancelled.
You can view the virtual sessions here.



Chair: Agnieszka Chlon-Dominczak, Warsaw School of Economics

1. Health Expectancy Indicators: What Do They Measure?Vanessa di Lego , Vienna Institute of Demography.

2. Healthy and Active Life in Retirement Age: Case of LatviaJuris Krumins , University of Latvia; Atis Berzins, University of Latvia; Aleksandrs Dahs, University of Latvia; Denize Ponomarjova, University of Latvia.

3. Rethinking Morbidity Compression: Increasing Inequality in Age at Morbidity OnsetRosie Seaman , Max Planck Institute for Demographic Research; Andreas Höhn, University of St. Andrews; Rune Lindahl-Jacobsen, Max Planck Odense Center on the Biodemography of Aging; Pekka Martikainen, University of Helsinki; Alyson A. Van Raalte, Max Planck Institute for Demographic Research (MPIDR); Kaare Christensen, University of Southern Denmark and Odense University Hospital.

4. ‘Expansion of Morbidity’ or ‘Dynamic Equilibrium’ in the Case of Diabetes? Changes of Disability Rates between 2004 and 2015 in Germany and the Role of Co-MorbidityStefanie Sperlich , Hannover Medical School; Johannes Beller, Hannover Medical School; Juliane Tetzlaff, Hannover Medical School; Jelena Epping, Hannover Medical School; Siegfried Geyer, Hannover Medical School.

5. Do Longer Lives Mean Better Health in Spain? Recent Trends in Disease-Free Life Expectancy at Age 65 YearsPilar Zueras , Institute for Social and Economic Research (ISER) - University of Essex; Elisenda Rentería, Centre d'Estudis Demogràfics.

Click on a name for contact information
Click on a title to see the abstract